Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes

Molecular Medicine

Volumn 12, Issue 9-10, 2006, Pages 221-228

  Tóth Zsámboki, Emese ^a   Horváth, Eszter ^b,c   Vargova, Katarina ^a   Pankotai, Eszter ^b   Murthy, Kanneganti ^d   Zsengellér, Zsuzsanna ^d   Bárány, Tamás ^b   Pék, Tamás ^b   Fekete, Katalin ^b   Kiss, Róbert Gábor ^a   Préda, István ^a   Lacza, Zsombor ^b   Gerö, Domokos ^c   Szabó, Csaba ^c,e,f  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c CellScreen Applied Research Center   (Hungary)

^d INOTEK CORPORATION   (United States)

^e Univ of Medicine & Denistry of   (United States)

^f University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; APOPTOSIS INDUCING FACTOR; FREE RADICAL; HYDROGEN PEROXIDE; LIPID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXIDIZING AGENT; TYROSINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CELL ENERGY; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DNA ADDUCT; DNA DAMAGE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE MIGRATION; LIPID PEROXIDATION; MALE; NECROSIS; NITRATION; NITROSATIVE STRESS; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REPERFUSION INJURY; ST SEGMENT ELEVATION;

AGED; ANGINA PECTORIS; APOPTOSIS INDUCING FACTOR; DEMOGRAPHY; DEOXYGUANOSINE; DNA DAMAGE; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; OXIDATION-REDUCTION; PEROXIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; TYROSINE;

EID: 33845539936     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00055.Toth-Zsamboki     Document Type: Article

References (32)

1. DeWood MA et al. (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Engl. J. Med. 303:897-902.
2. Braunwald E, Kloner RA. (1985) Myocardial reperfusion. A double-edged sword? J. Clin. Invest. 76:1713-9.
3. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. (2005) Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 100:179-90.
4. Piper HM, Meuter K, Schafer C. (2003) Cellular mechanism of ischemia-reperfusion injury. Ann. Thorac. Surg. 75:644-8.
5. Zweier JL. (1988) Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J. Biol. Chem. 263:1353-7.
6. Maxwell SRJ, Lip GYH. (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestation and therapeutic options. Int. J. Cardiol. 58:95-117.
7. Virág L, Szabó C. (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:375-429.
8. Nguewa PA et al. (2005) Poly(ADP-ribose) polymerases: Homology, structural domains and functions. Novel therapeutical applications. Prog. Biophys. Mol. Biol. 88:143-72.
9. Graziani G, Szabó C. (2005) Clinical perspectives of PARP inhibitors. Pharmacol. Res. 52:109-18.
10. Szabó C. (2005) Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol. Res. 52:34-43.
11. Gilad E et al. (1997) Protection by inhibition of poly(ADP ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J. Mol. Cell Cardiol. 29:2585-97.
12. Kirkland JB. (1994) Lipid peroxidation, protein thiol oxidation and DNA damage hydrogen-peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose) polymerase. Biochim. Biophys. Acta. 1092:319-25.
13. Chen M et al. (2004) Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. Cardiovasc. Res. 63:682-8.
14. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabo C. (1997) Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc. Res. 36:205-15.
15. Halmosi R et al. (2001) Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol. Pharmacol. 59:1497-505.
16. Liaudet L et al. (2001) Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br. J. Pharmacol. 133:1424-30.
17. Carrillo A et al. (2004) Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells. Nucleic Acids Res. 32:757-66.
18. Piconi L et al. (2004) Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose)polymerase. J. Thromb. Haemost. 2:1453-9.
19. Zingarelli B, Salzman AL, Szabo C. (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83:85-94.
20. Khan TA et al. (2003) Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass. J. Am. Coll. Surg. 197:270-7.
21. Murthy KG et al. (2004) Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction. Shock. 21:230-4.
22. Jagtap P, Szabo C. (2005) Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 4:421-40.
23. Eltzschig HK, Collard CD. (2004) Vascular ischaemia and reperfusion injury. Br. Med. Bull. 70:71-86.
24. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 347:781-6.
25. Chouairi S, Carrie D, Puel J. (1995) Myocardial protection with calcium-channel blockers during ischaemia and reperfusion by PTCA. Eur. Heart J. 16 Suppl H:3-8.
26. Ferrari R, Pepi P, Ferrari F, Nesta F, Benigno M, Visioli O. (1998) Metabolic derangement in ischemic heart disease and its therapeutic control. Am. J. Cardiol. 82:2K-13K.
27. Thiemermann C et al. (1997) Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 94:679-83.
28. Yang Z, Zingarelli B, Szabo C. (2000) Effect of genetic disruption of poly(ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock. 13:60-6.
29. Califf RM et al. (1998) Myonecrosis after revascularization procedures. J. Am. Coll. Cardiol. 31:241-51.
30. Narins CR, Miller DP, Califf RM, Topol EJ. (1999) The relationship between periprocedural myocardial infarction and subsequent target vessel revascuiarization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. J. Am. Coll. Cardiol. 33:647-53.
31. Akkerhuis KM et al. (2002) Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 105:554-6.
32. Virag L, Szabo E, Gergely P, Szabo C. (2003) Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140-141:113-24.